Antimicrobial agent prescription patterns for chemotherapy-induced febrile neutropenia in patients with hematological malignancies at Sultan Qaboos University Hospital, Oman

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Objectives: The aim of this study was to describe the antimicrobial prescription patterns of patients with hematological malignancies who developed febrile neutropenia (FN) at Sultan Qaboos University Hospital (SQUH) in Oman. Methods: This was a retrospective observational study covering a period of 3 years (January 2007-February 2010). FN episodes were studied in patients with hematological malignancies in three different wards at SQUH. Results: A total of 176 FN episodes were analyzed. Overall, 64% of the 107 patients studied experienced at least 2 episodes during the analysis period. Approximately, 69% of the febrile neutropenia episodes had severe neutropenia. The duration of neutropenia was less than 1 week in the majority of the episodes (57%). The mean duration of treatment was approximately 7 days, with no significant difference between specialties or different types of malignancies. Only 34 (19%) episodes had positive cultures, and most of these were from blood samples (30 episodes, 88%). The majority of isolates were gram-negative organisms (63%). The initial empirical treatment included monotherapy (37%), dual therapy (60%) and triple therapy (3%). Conclusions: This study demonstrates that there is a large variation in the antimicrobial treatment of FN episodes in patients with hematological malignancies at SQUH. All chosen drugs were within international guideline recommendations.

Original languageEnglish
Pages (from-to)216-221
Number of pages6
JournalJournal of Infection and Public Health
Volume6
Issue number3
DOIs
Publication statusPublished - Jun 2013

Fingerprint

Chemotherapy-Induced Febrile Neutropenia
Oman
Febrile Neutropenia
Hematologic Neoplasms
Anti-Infective Agents
Prescriptions
Neutropenia
Therapeutics
Observational Studies
Retrospective Studies
Demography
Sultan
Guidelines
Pharmaceutical Preparations

Keywords

  • Antimicrobials
  • Chemotherapy
  • Fever
  • Malignancy
  • Neutropenia

ASJC Scopus subject areas

  • Infectious Diseases
  • Public Health, Environmental and Occupational Health

Cite this

@article{498f6a15da7340819520efcae7681e98,
title = "Antimicrobial agent prescription patterns for chemotherapy-induced febrile neutropenia in patients with hematological malignancies at Sultan Qaboos University Hospital, Oman",
abstract = "Objectives: The aim of this study was to describe the antimicrobial prescription patterns of patients with hematological malignancies who developed febrile neutropenia (FN) at Sultan Qaboos University Hospital (SQUH) in Oman. Methods: This was a retrospective observational study covering a period of 3 years (January 2007-February 2010). FN episodes were studied in patients with hematological malignancies in three different wards at SQUH. Results: A total of 176 FN episodes were analyzed. Overall, 64{\%} of the 107 patients studied experienced at least 2 episodes during the analysis period. Approximately, 69{\%} of the febrile neutropenia episodes had severe neutropenia. The duration of neutropenia was less than 1 week in the majority of the episodes (57{\%}). The mean duration of treatment was approximately 7 days, with no significant difference between specialties or different types of malignancies. Only 34 (19{\%}) episodes had positive cultures, and most of these were from blood samples (30 episodes, 88{\%}). The majority of isolates were gram-negative organisms (63{\%}). The initial empirical treatment included monotherapy (37{\%}), dual therapy (60{\%}) and triple therapy (3{\%}). Conclusions: This study demonstrates that there is a large variation in the antimicrobial treatment of FN episodes in patients with hematological malignancies at SQUH. All chosen drugs were within international guideline recommendations.",
keywords = "Antimicrobials, Chemotherapy, Fever, Malignancy, Neutropenia",
author = "{Al Balushi}, {K. A.} and A. Balkhair and Ali, {B. H.} and {Al Rawas}, N.",
year = "2013",
month = "6",
doi = "10.1016/j.jiph.2012.12.005",
language = "English",
volume = "6",
pages = "216--221",
journal = "Journal of Infection and Public Health",
issn = "1876-0341",
publisher = "Elsevier BV",
number = "3",

}

TY - JOUR

T1 - Antimicrobial agent prescription patterns for chemotherapy-induced febrile neutropenia in patients with hematological malignancies at Sultan Qaboos University Hospital, Oman

AU - Al Balushi, K. A.

AU - Balkhair, A.

AU - Ali, B. H.

AU - Al Rawas, N.

PY - 2013/6

Y1 - 2013/6

N2 - Objectives: The aim of this study was to describe the antimicrobial prescription patterns of patients with hematological malignancies who developed febrile neutropenia (FN) at Sultan Qaboos University Hospital (SQUH) in Oman. Methods: This was a retrospective observational study covering a period of 3 years (January 2007-February 2010). FN episodes were studied in patients with hematological malignancies in three different wards at SQUH. Results: A total of 176 FN episodes were analyzed. Overall, 64% of the 107 patients studied experienced at least 2 episodes during the analysis period. Approximately, 69% of the febrile neutropenia episodes had severe neutropenia. The duration of neutropenia was less than 1 week in the majority of the episodes (57%). The mean duration of treatment was approximately 7 days, with no significant difference between specialties or different types of malignancies. Only 34 (19%) episodes had positive cultures, and most of these were from blood samples (30 episodes, 88%). The majority of isolates were gram-negative organisms (63%). The initial empirical treatment included monotherapy (37%), dual therapy (60%) and triple therapy (3%). Conclusions: This study demonstrates that there is a large variation in the antimicrobial treatment of FN episodes in patients with hematological malignancies at SQUH. All chosen drugs were within international guideline recommendations.

AB - Objectives: The aim of this study was to describe the antimicrobial prescription patterns of patients with hematological malignancies who developed febrile neutropenia (FN) at Sultan Qaboos University Hospital (SQUH) in Oman. Methods: This was a retrospective observational study covering a period of 3 years (January 2007-February 2010). FN episodes were studied in patients with hematological malignancies in three different wards at SQUH. Results: A total of 176 FN episodes were analyzed. Overall, 64% of the 107 patients studied experienced at least 2 episodes during the analysis period. Approximately, 69% of the febrile neutropenia episodes had severe neutropenia. The duration of neutropenia was less than 1 week in the majority of the episodes (57%). The mean duration of treatment was approximately 7 days, with no significant difference between specialties or different types of malignancies. Only 34 (19%) episodes had positive cultures, and most of these were from blood samples (30 episodes, 88%). The majority of isolates were gram-negative organisms (63%). The initial empirical treatment included monotherapy (37%), dual therapy (60%) and triple therapy (3%). Conclusions: This study demonstrates that there is a large variation in the antimicrobial treatment of FN episodes in patients with hematological malignancies at SQUH. All chosen drugs were within international guideline recommendations.

KW - Antimicrobials

KW - Chemotherapy

KW - Fever

KW - Malignancy

KW - Neutropenia

UR - http://www.scopus.com/inward/record.url?scp=84877646286&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84877646286&partnerID=8YFLogxK

U2 - 10.1016/j.jiph.2012.12.005

DO - 10.1016/j.jiph.2012.12.005

M3 - Article

C2 - 23668467

AN - SCOPUS:84877646286

VL - 6

SP - 216

EP - 221

JO - Journal of Infection and Public Health

JF - Journal of Infection and Public Health

SN - 1876-0341

IS - 3

ER -